| |
| |
|
| Insider
Information: |
Hunt Ronald |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
100,015,193 |
|
|
Indirect Shares
|
9,085,133 |
|
|
| Direct
Value |
$26,914 |
|
|
|
Indirect Value
|
$5,547,605 |
|
|
| Total
Shares |
109,100,326 |
|
|
| Total
Value |
$5,574,519 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -16.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
World Heart Corp |
WHRT |
10% Owner |
2008-07-31 |
100,000,000 |
|
0 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
Director, 10% Owner |
2012-07-24 |
0 |
2012-07-24 |
3,028,439 |
Premium* |
|
|
Relypsa Inc |
RLYP |
Former 10% beneficial ... |
2013-11-20 |
0 |
2013-11-20 |
2,114,890 |
Premium* |
|
|
Iterum Therapeutics Plc |
ITRM |
Director |
2023-10-01 |
14,346 |
2023-10-01 |
97,086 |
Premium* |
|
|
Neuronetics Inc |
STIM |
Director, 10% Owner |
2019-04-01 |
847 |
2019-04-01 |
1,543,115 |
Premium* |
|
|
Harpoon Therapeutics, Inc. |
HARP |
|
2024-03-11 |
0 |
2024-03-11 |
0 |
Premium* |
|
|
Rallybio Corp |
RLYB |
Director |
2021-07-28 |
0 |
2021-08-02 |
2,301,603 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HARP |
Harpoon Therapeutics, Inc... |
|
– • • |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(10,000) |
0 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
|
– • • |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,859,169) |
0 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
|
– • • |
2024-03-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,224) |
0 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
|
– • • |
2024-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
424 |
13,224 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
|
– • • |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,072 |
12,801 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2023-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
11,729 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2023-10-25 |
4 |
B |
$0.00 |
$0 |
I/I |
1,543,500 |
395,783 |
2.17 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2023-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,035 |
6,729 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,479 |
14,346 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2023-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,656 |
36,941 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,796 |
8,867 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2023-03-23 |
4 |
B |
$1,000.00 |
$10,000,000 |
I/I |
10,000 |
10,000 |
2.25 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,197 |
4,030 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-06-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,798 |
42,501 |
0 |
- |
|
| RLYB |
Rallybio Corp |
Director |
– • – |
2021-08-02 |
4 |
B |
$13.00 |
$3,999,996 |
I/I |
307,692 |
2,301,603 |
2.1 |
- |
|
| RLYB |
Rallybio Corp |
Director |
– • – |
2021-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
1,993,911 |
1,993,911 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2021-01-11 |
4 |
B |
$17.00 |
$3,999,998 |
I/I |
235,294 |
913,860 |
2.25 |
% |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2020-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,703 |
5,703 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • • |
2019-04-01 |
4 |
A |
$14.75 |
$12,493 |
D/D |
847 |
847 |
0 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2019-02-12 |
4 |
B |
$14.00 |
$5,999,994 |
I/I |
428,571 |
678,566 |
2.25 |
- |
|
| HARP |
Harpoon Therapeutics, Inc... |
Director |
– • • |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
I/I |
2,492,834 |
464,281 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • • |
2018-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
1,543,115 |
1,543,115 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • • |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
I/I |
793,626 |
793,626 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • • |
2018-05-30 |
4 |
B |
$13.00 |
$8,614,801 |
I/I |
662,677 |
384,615 |
2.25 |
- |
|
| RLYP |
Relypsa Inc |
Former 10% beneficial owner |
– • – |
2013-11-20 |
4 |
B |
$11.00 |
$2,045,758 |
I/I |
185,978 |
2,114,890 |
2.1 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
